Cover Image
市場調查報告書

介入心臟病學的全球市場:2017年∼2027年 - 經皮冠狀動脈形成術 (PCI)、經導管主動脈瓣置入術 (TAVI)、經導管二尖瓣置換術 (TMVR)

Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR)

出版商 Visiongain Ltd 商品編碼 220570
出版日期 內容資訊 英文 225 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
介入心臟病學的全球市場:2017年∼2027年 - 經皮冠狀動脈形成術 (PCI)、經導管主動脈瓣置入術 (TAVI)、經導管二尖瓣置換術 (TMVR) Global Interventional Cardiology Market 2017-2027: Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Implantation (TMVR)
出版日期: 2017年01月31日 內容資訊: 英文 225 Pages
簡介

全球介入心臟病學市場,預計從2017年到2027年以15.0%的年複合成長率發展,到2021年達139億2,000萬美元,2027年達355億3,700萬美元的規模。

本報告提供介入心臟病學市場現狀與今後10年與的預測,市場優勢弱點,新的商務的機會等彙整資料,並將其結果為您概述為以下內容。

第1章 報告概要

第2章 介入心臟病學的簡介

  • 介入心臟病學概要
  • 冠狀動脈疾病 (CAD)
    • CAD治療的內科治療及外科治療
    • 經皮冠狀動脈形成術 (PCI)
    • 介入性心臟病的進步
  • 主動脈閥狹窄症(AS)
    • 定義
    • AS治療的內科治療及外科治療
    • 主動脈閥移植術的演進
  • 二尖瓣逆流症 (MR)
    • MR治療的內科治療及外科治療
    • 二尖瓣形成術的演進

第3章 全球介入心臟病學市場

  • 市場概要
  • 全球市場
  • 銷售額及市場預測
  • 各分類市場佔有率預測
  • 市場成長的促進要素及抑制因素

第4章 全球經皮冠狀動脈形成術 (PCI) 市場

  • 概要
  • 全球市場
  • 全球市場:支架的各類型市場及市場佔有率預測
  • 競爭情形 (市場佔有率分析)
  • PCI市場市場動態
  • 開發平台分析
  • 償付(各國)

第5章 全球經導管主動脈瓣置換術 (TAVI/TAVR) 市場

  • 市場概要
  • 競爭情形 (市場佔有率分析)
  • 市場動態
  • SWOT分析
  • 開發中產品
  • 償付 (各國)

第6章 全球經導管主動脈瓣置入術 (TAVI) 市場

  • 市場概要
  • 競爭情形 (市場佔有率分析)
  • 市場動態
  • SWOT分析
  • 開發平台分析
  • 償付 (各國)

第7章 各國分析

  • 各地區明細
  • 各地區市場佔有率預測
  • 美國市場
  • 德國市場
  • 法國市場
  • 義大利市場
  • 西班牙市場
  • 英國市場
  • 日本市場
  • 澳洲市場
  • 新加坡市場
  • 中國市場
  • 印度市場
  • 其他

第8 企業簡介

  • Abbott Vascular
  • Edwards Lifesciences
  • Medtronic Plc
  • Boston Scientific
  • Sysmetis
  • Cardiac Dimensions

第9章 SWOT/STEP分析

第10章 開發平台分析

第11章 建議及結論

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0165

The global interventional cardiology market is expected to grow at a CAGR of 11.1% in the first half of the forecast period and CAGR of 16.9% in the second half of the forecast period. The market is expected to grow at a CAGR of 15.0% from 2017 to 2027. The market is estimated at $13,920m in 2021 and $35,537m in 2027.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 225-page report you will receive 111 charts - all unavailable elsewhere.

The 225-page report provides clear detailed insight into the global interventional cardiology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

image1

Report Scope

  • Global Interventional Cardiology Market forecasts from 2017-2027
  • Percutaneous Coronary Intervention (PCI) submarket forecasts from 2017-2027, further segmented into:
    • Drug-eluting Stents (DES)
    • Bare Metal Stents
    • Bioresorbable Stents

This section also discusses the leading products, competitive landscape, market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for PCI in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.

  • Transcatheter Aortic Valve Implantation (TAVI/TAVR) from 2017-2027
    • This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TAVI/TAVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
  • Trans Mitral Valve Implantation (TMVR) submarket forecasts from 2017-2027
    • This section also discusses the market share of the leading players, drivers & restraints, pipeline analysis, SWOT analysis, reimbursement schemes for TMVR in the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China and India.
  • Interventional Cardiology Leading National Market forecasts from 2017-2027 covering the US, Germany, France, Italy, Spain, the UK, Japan, Australia, Singapore, China, India and the Rest of the World (RoW)

Each country is further segmented into PCI, TAVI and TMVR.

  • Assessment of selected leading companies that hold major market shares in the interventional cardiology market
  • SWOT and STEP analysis of the global interventional cardiology market

Visiongain's study is intended for anyone requiring commercial analyses for the Global Interventional Cardiology Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Interventional Cardiology Market Overview
  • 1.2 World Interventional Cardiology Market Segmentation
  • 1.3 Overview of Findings
  • 1.4 Structure of the Report
  • 1.5 Why You Should Read This Report
  • 1.6 How this Report Delivers
  • 1.7 Key Questions Answered by this Analytical Report
  • 1.8 Who is this Report For?
  • 1.9 Research Methodology
    • 1.9.1 Primary Research
    • 1.9.2 Secondary Research
    • 1.9.3 Market Evaluation & Forecasting Methodology
  • 1.10 Frequently Asked Questions
  • 1.11 Associated Visiongain Reports:
  • 1.12 About Visiongain

2. Introduction to Interventional Cardiology

  • 2.1 An Introduction to Interventional Cardiology Market
  • 2.2 Coronary Artery Disease:
    • 2.2.1 Medical Procedures and Surgical Interventions for treatment of CAD:
    • 2.2.2 Percutaneous Coronary Intervention (PCI):
    • 2.2.3 Evolution of Interventional Cardiology
  • 2.3 Aortic Stenosis
    • 2.3.1 Definition:
    • 2.3.2 Medical Procedures and Surgical Interventions for treatment of Aortic Stenosis (AS):
    • 2.3.3Evolution of Trans Aortic Valve Implantation
  • 2.4 Mitral Valve Regurgitation
    • 2.4.1 Medical Procedures and Surgical Interventions for treatment of Mitral Regurgitation (MR):
    • 2.4.2 Evolution of Trans Mitral Valve Repair

3. Interventional Cardiology: World Market 2017-2027

  • 3.1 Interventional Cardiology: World Market Overview, 2016
  • 3.2 The World Interventional Cardiology Market
  • 3.3 World Interventional Cardiology Market: Sales and Forecast 2017-2027
  • 3.4 Changing Market Shares by Segment 2017-2027
  • 3.5 World Interventional Cardiology Drivers and Restraints, 2017-2027

4. Percutaneous Coronary Intervention: World Market (PCI) 2017-2027

  • 4.1 Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
  • 4.2 The Global Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
  • 4.3 The Global Percutaneous Coronary Intervention (PCI): Global Market Overview, 2016
  • 4.4 The Global Percutaneous Coronary Intervention (PCI): Global Market by Type of Stents and Changing Market Shares, 2016
  • 4.5 Competitive Landscape (Market share Analysis (%), 2015)
  • 4.6 Market Dynamics of PCI Market, 2015
  • 4.7 Pipeline Analysis of PCI Market, 2015 to 2027
    • 4.7.1 New Technological Innovations to revive the mature coronary stents market
    • 4.7.2 Greater Effectiveness of Bioasorbable Vascular Scaffolds
    • 4.7.3 Strong R&D Pipeline: To Drive the Market Growth
    • 4.7.4 Rising Prevalence of Coronary Artery Disease
    • 4.7.5 Use of Bioresorbable vascular scaffolds for treatment of CAD
    • 4.7.6 Dominance of major players is a major barrier for new and small entrants
    • 4.7.7 Lack of reimbursement for certain PCI segments restricts the market growth
    • 4.7.8 Competition from drug manufacturers
    • 4.7.9 DES stent manufacturers may face internal competition from BVS manufacturers
  • 4.8 Reimbursement for PCI
    • 4.8.1 US PCI Reimbursement
    • 4.8.2 Germany PCI Reimbursement
    • 4.8.3 France PCI Reimbursement
    • 4.8.4 Italy PCI Reimbursement
    • 4.8.5 Spain PCI Reimbursement
    • 4.8.6 UK PCI Reimbursement
    • 4.8.7 Japan PCI Reimbursement
    • 4.8.8 Australia PCI Reimbursement
    • 4.8.9 Singapore PCI Reimbursement
    • 4.8.10 China PCI Reimbursement
    • 4.8.11 India PCI Reimbursement

5. Trans Aortic Valve Implantation (TAVI/ TAVR): World Market 2017-2027

  • 5.1 Trans Aortic Valve Implantation (TAVI/TAVR): Global Market Overview, 2016
  • 5.2 Competitive Landscape (Market share Analysis (%), 2015)
  • 5.3 Market Dynamics of TAVR Market, 2016
  • 5.4 SWOT Analysis of TAVR Market, 2016
    • 5.4.1 New Technological Innovations are driving the TAVR market
    • 5.4.2 Growing Favourable Reimbursement to provide an impetus for TAVR penetration
    • 5.4.3 Growing adoption in Emerging market
    • 5.4.4 Application of TAVR devices in intermediate and low risk patients
    • 5.4.5 Need for trained interventional cardiologists
    • 5.4.6 High cost of the TAVR device and procedure
    • 5.4.7 Surgical Valve implant procedures
    • 5.4.8 New market entrants with differentiated products
  • 5.5 TAVR Pipeline Products - 2016-2027
  • 5.6 Reimbursement for TAVR
    • 5.6.1 US TAVR Reimbursement:
    • 5.6.2 Germany TAVR Reimbursement:
    • 5.6.3 France TAVR Reimbursement:
    • 5.6.4 Italy TAVR Reimbursement:
    • 5.6.5 UK TAVR Reimbursement:
    • 5.6.6 Spain TAVR Reimbursement:
    • 5.6.7 Japan TAVR Reimbursement:
    • 5.6.8 Australia TAVR Reimbursement:
    • 5.6.9 Singapore TAVR Reimbursement:
    • 5.6.10 China TAVR Reimbursement:
    • 5.6.11 India TAVR Reimbursement:

6. Trans Mitral Valve Implantation (TMVR): World Market 2017-2027

  • 6.1 Trans Mitral Valve Implantation (TMVR): Global Market Overview, 2016
  • 6.2 Competitive Landscape (Market share Analysis (%), 2015)
  • 6.3 Market Dynamics of TMVR Market, 2016
  • 6.4 SWOT Analysis of TMVR Market, 2016
    • 6.4.1 New Technological Innovations
    • 6.4.2 Encouraging reimbursement policies
    • 6.4.3 Application of TMVR devices in Functional Mitral Regurgitation patients
    • 6.4.4 Regulatory Approvals outside US and Europe
    • 6.4.5 Financial hurdles cripple the market growth
    • 6.4.6 Product recall and lack of trained surgeons may stymie the growth
    • 6.4.7 Surgical Valve implant procedures
    • 6.4.8 New market entrants with complementary products
  • 6.5 TMVR Pipeline Analysis 2016-2027
  • 6.6 Reimbursement for TMVR
    • 6.6.1 US TMVR Reimbursement:
    • 6.6.2 Germany TMVR Reimbursement:
    • 6.6.3 France TMVR Reimbursement:
    • 6.6.4 Italy TMVR Reimbursement:
    • 6.6.5 UK TMVR Reimbursement:
    • 6.6.6 Spain TMVR Reimbursement:
    • 6.6.7 Japan TMVR Reimbursement:
    • 6.6.8 Australia TMVR Reimbursement:
    • 6.6.9 Singapore TAVR Reimbursement:
    • 6.6.10 China TMVR Reimbursement:
    • 6.6.11 India TMVR Reimbursement:

7. Leading National Markets 2017-2027

  • 7.1 Geographical Breakdown of Interventional Cardiology Market
  • 7.2 How will the regional market shares change by 2027?
  • 7.3 The U.S. Interventional Cardiology Market 2017-2027
  • 7.3.1 US Interventional Cardiology Market: Trends and Developments
  • 7.4 Germany Interventional Cardiology Market 2017-2027
  • 7.5 France Interventional Cardiology Market 2017-2027
  • 7.6 Italy Interventional Cardiology Market 2017-2027
  • 7.7 Spain Interventional Cardiology Market 2017-2027
  • 7.8 UK Interventional Cardiology Market 2017-2027
  • 7.9 Japan Interventional Cardiology Market 2017-2027
  • 7.10 Australia Interventional Cardiology Market 2017-2027
  • 7.11 Singapore Interventional Cardiology Market 2017-2027
  • 7.12 China Interventional Cardiology Market 2017-2027
  • 7.13 India Interventional Cardiology Market 2017-2027
  • 7.14 Rest of World (RoW) Interventional Cardiology Market 2017-2027

8. Company Profiles

  • 8.1 Abbott Vascular
    • 8.1.1 Abbott Vascular: Interventional Cardiology Product Portfolio
    • 8.1.2 Abbott Vascular: Financial Overview
    • 8.1.3 List of Product approvals
    • 8.1.4 Recent Developments
  • 8.2 Edwards Lifesciences
    • 8.2.1 Edwards Lifesciences Product Portfolio:
    • 8.2.2 Edwards Lifesciences: Financial Overview:
    • 8.2.3 Recent Developments
  • 8.3 Medtronic Plc
    • 8.3.1 Medtronic's Product Portfolio
    • 8.3.2 Medtronic's Financial Overview
    • 8.3.3 Medtronic's Recent Developments
  • 8.4 Boston Scientific
    • 8.4.1 Boston Scientific Product Portfolio
    • 8.4.2 Boston Scientific Financial Overview
    • 8.4.3 Recent Developments:
  • 8.5 Sysmetis
    • 8.5.1 Financial Overview:
    • 8.5.2 Product Portfolio:
  • 8.6 Cardiac Dimensions
    • 8.6.1 Financial Overview:
    • 8.6.2 Product Portfolio:
    • 8.6.3 Recent Developments:
    • 8.6.4 Direct Flow Medical Inc.
    • 8.6.5 Product Portfolio:
    • 8.6.6 Financial Overview

9. SWOT and STEP Analysis of the Interventional Cardiology Market 2017-2027

  • 9.1 Strengths
    • 9.1.1 Product innovation
    • 9.1.2 Strong distribution network
    • 9.1.3 Robust R&D
    • 9.1.4 Brand Image
  • 9.2 Weaknesses
    • 9.2.1 High costs of the devices
    • 9.2.2 Lack of effective reimbursement
    • 9.2.3 Delayed regulatory approvals
  • 9.3 Opportunities
    • 9.3.1 Leverage the established market presence
    • 9.3.2 To tap the unmet needs of the industry
  • 9.4 Threats
    • 9.4.1 Intense competition from small players engaged in price wars for PCI market
    • 9.4.2 New entrants in TMVR and TAVR market can pose threat for big players
  • 9.5 Social
  • 9.6 Technological
  • 9.7 Political/ Legal

10. Pipeline Analysis of Interventional Cardiology Market, 2016 to 2027

  • 10.1 PCI Market Pipeline Products - 2016-2027
  • 10.2 TAVR Pipeline Products - 2016-2027
  • 10.3 TMVR Pipeline Analysis 2016-2027

11. Recommendations & Conclusions

  • 11.1 The World Interventional Cardiology Market 2016 and 2017
  • 11.2 Current Leading Interventional Cardiology Segments
  • 11.3 Leading Interventional Cardiology Companies
  • 11.4 Leading Countries for Interventional Cardiology
  • 11.5 World Interventional Cardiology Market Forecast 2017-2027
  • 11.6 The Future of Interventional Cardiology Market Forecast 2017-2027
  • Some Associated Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain Report Evaluation Form

List of Tables

  • Table 1.1 (Sample) Global Interventional Cardiology Market: Revenue ($m), AGR (%), CAGR (%) by Country, 2016-2027
  • Table 3.1 Global Interventional Cardiology Market: Revenue ($m) and Market Share (%) by Segment, 2016
  • Table 3.2 Global Interventional Cardiology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 4.1 Global Percutaneous Coronary Stent Market: Revenue ($m) and Market Share (%) by Segment, 2016
  • Table 4.2 Global Percutaneous Coronary Stent Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 4.3 List of Companies, their Stent System and Type of Polymer used
  • Table 4.4 Pipeline Analysis of PCI Market, 2015-2027
  • Table 4.5 SWOT Analysis of PCI Market,2015-2027
  • Table 5.1 Global TAVR Market Forecast: Revenue ($m), AGR (%) & CAGR (%), 2016-2027
  • Table 5.2 SWOT Analysis of TAVR Market,2016
  • Table 5.3 Technological Innovations of Interventional Cardiology Product
  • Table 5.4 Upcoming Interventional Cardiology Medical Imaging Technologies
  • Table 5.5 TAVR Product Pipeline, 2015-2020
  • Table 5.6 TAVR Product Pipeline, 2015-2020
  • Table 6.1 Global Trans-Mitral Valve Market (TMVR) Forecast: Revenue ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 6.2 SWOT Analysis of TMVR Market, 2015-2027
  • Table 6.3 TMVR Product Pipeline Analysis, 2015-2027
  • Table 6.4 Transcatheter mitral valve repair technology under development, 2016-2027
  • Table 6.5 Transcatheter mitral valve repair technology under development, 2016-2027
  • Table 7.1 Global Interventional Cardiology Market by Country: Revenue ($m) and Market Share (%) by Segment, 2016
  • Table 7.2 Projections of Crude CVD Prevalence (%), 2010-2030 in the United States
  • Table 7.3 US Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.4 US Interventional Cardiology Market Forecast: Revenues ($m), by Segment, AGR (%) and CAGR (%), 2016-2027
  • Table 7.5 Germany Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.6 Germany Interventional Cardiology Market Forecast: Revenues ($m), by Segment, AGR (%) and CAGR (%), 2016-2027
  • Table 7.7 France Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.8 France Interventional Cardiology Market Forecast: Revenues by Segment, ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.9 Italy Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.10 Italy Interventional Cardiology Market Forecast: Revenues by Segment, ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.11 Spain Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.12 Spain Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.13 UK Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.14 UK Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.15 Japan Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.16 Japan Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%) 2016-2027
  • Table 7.17 Australia Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.18 Australia Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.19 Singapore Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.20 Singapore Interventional Cardiology Market Forecast: Revenues by Segment ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.21 China Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.22 China Interventional Cardiology Market Forecast: Revenues ($m) by Segments, AGR (%) and CAGR (%), 2016-2027
  • Table 7.23 India Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.24 India Interventional Cardiology Market Forecast: Revenues by Segments ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.25 ROW Interventional Cardiology Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 7.26 ROW Interventional Cardiology Market Forecast: Revenues, By Segments ($m), AGR (%) and CAGR (%), 2016-2027
  • Table 8.1 Abbott Vascular: Business Overview, 2016
  • Table 8.2 Abbott Vascular: List of Interventional Cardiology Product Approval
  • Table 8.3 Edwards Lifesciences: Overview, 2016
  • Table 8.4 Medtronic Plc: Overview, 2016
  • Table 8.5 Boston Scientific Group: Overview, 2016
  • Table 8.6 Sysmetis Overview: 2016
  • Table 8.7 Cardiac Dimensions Overview: 2016
  • Table 8.8 Direct Flow Overview: 2016
  • Table 10.1 Global Pipeline Analysis of PCI Market, 2015-2027
  • Table 10.2 Global Pipeline Analysis of PCI Market, 2015-2027
  • Table 10.3 Transcatheter mitral valve repair technology under development, 2016-2027
  • Table 10.4 Transcatheter mitral valve repair technology under development, 2016-2027
  • Table 11.1 Leading Countries for Interventional Cardiology Snapshot,2017

List of Figures

  • Figure 1.1 World Death Number, By Region, 2010
  • Figure 1.2 World Interventional Cardiology Market Segmentation
  • Figure 2.1 Percutaneous Coronary Intervention, Procedure
  • Figure 2.2 Percutaneous Coronary Intervention, Procedure
  • Figure 2.3 Evolution of Interventional Cardiology
  • Figure 2.4 Aortic Stenosis
  • Figure 2.5 Surgical Aortic Valve Surgery
  • Figure 2.6 Trans-Aortic Valve Surgery (TAVR)
  • Figure 2.7 Evolution of Trans Aortic Valve Implantation
  • Figure 2.8 Evolution of Trans Mitral Valve Implantation (TMVR)
  • Figure 3.1 Global Interventional Cardiology Market: Revenue ($m) by Segment, 2016
  • Figure 3.2 Global Interventional Cardiology Device: Market Share (%) by Segment, 2016
  • Figure 3.3 Global Interventional Cardiology Devices Market: Revenue ($m) 2016-2027
  • Figure 3.4 Global Interventional Cardiology Devices Market by Segment: Market Shares (%), 2016
  • Figure 3.5 Global Interventional Cardiology Devices Market by Segment: Market Shares (%), 2027
  • Figure 4.1 Global Percutaneous Coronary Intervention Market by Type: Market Share (%), 2016
  • Figure 4.2 Global Percutaneous Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
  • Figure 4.3 Global Percutaneous Coronary Stent Market by Product Type: Market Share (%), 2016
  • Figure 4.4 Global Percutaneous Coronary Stent Market by Product Type: Market Share (%), 2027
  • Figure 4.5 Global Bare Metal Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
  • Figure 4.6 Global Drug Eluting Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
  • Figure 4.7 Global Bioresorbable Vascular Scaffold (BVS) Coronary Stent Market Forecast: Revenue ($m) and AGR (%), 2016-2027
  • Figure 4.8 Global Percutaneous Coronary Stents Market Share (%), 2015
  • Figure 4.9 PCI Market: Drivers and Restraints, 2017-2027
  • Figure 5.1 Global TAVR Market by Revenue ($m) & AGR (%), 2016-2027
  • Figure 5.2 Global TAVR Market Share Analysis (%), 2015
  • Figure 5.3 Global TAVR Market Drivers & Restraints, 2016-2027
  • Figure 6.1 Transcatheter Mitral Valve Market Forecast: 2016-2027 ($m, AGR %)
  • Figure 6.2 Transcatheter Mitral Valve Market Share Analysis: 2015 (%)
  • Figure 6.3 Transcatheter Mitral Valve Market Dynamics, 2016
  • Figure 7.1 Global Interventional Cardiology Market by Country ($m), 2017
  • Figure 7.2Global Interventional Cardiology Market by Country: Revenues ($m), 2017-2027
  • Figure 7.3 Global Interventional Cardiology Market by Country: Market shares (%), 2016
  • Figure 7.4 Global Interventional Cardiology Market by Country: Market Shares(%), 2027
  • Figure 7.5 US Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.6 Germany Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.7 France Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.8 Italy Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.9 Spain Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.10 UK Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
  • Figure 7.11 Japan Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
  • Figure 7.12 Australia Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.13 Singapore Interventional Cardiology Market by Revenue ($m), AGR (%),2016-2027
  • Figure 7.14 China Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.15 India Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 7.16 RoW Interventional Cardiology Market by Revenue ($m), AGR (%), 2016-2027
  • Figure 8.1 Abbott Vascular Revenues: 2013-2015 ($m)
  • Figure 8.2 Edwards Lifesciences: Financial Overview, 2013-2015
  • Figure 8.3 Medtronic Plc.: Financial Overview, 2013-2015
  • Figure 8.4 Medtronic Plc.: Financial Overview, 2013-2015
  • Figure 9.1 Global Interventional Cardiology Market: SWOT Analysis, 2016
  • Figure 9.2 Global Interventional Cardiology Market: STEP Analysis, 2016
  • Figure 10.1 TAVR Pipeline Market: 2015-2020

Companies Listed

  • 3mensio Medical Imaging
  • Abbott
  • Accucinch
  • Alvimedica
  • Amaranth Medical
  • Aperture Venture Partners
  • Arterial Remodelling Technologies
  • B.Braun
  • Balton
  • Biosensors International
  • Biotronik
  • Boston Scientific Group
  • British Heart Foundation
  • Caisson
  • Cardiac Dimensions
  • CardiAQ
  • Cardica
  • Cardiosolutions
  • Centre for Disease and Prevention Control (CDC)
  • Centres for Medicare & Medicaid Services
  • Cordis
  • Direct Flow Medical
  • Edwards Lifesciences
  • Elixir Medical Corporation
  • Emory University
  • European Society for Cardiology
  • FDA
  • HighLife
  • JenaValve
  • JW Medical Systems
  • Kardium
  • Kyoto Medical Planning
  • Lepu Medical Technology
  • Life Science Partners
  • Mardil Medical
  • Medfavour Medical Co., Ltd.
  • Medtronic
  • Micell Technologies
  • Microport Scientific
  • Milipede
  • Ministry of Health Labor and Welfare (MHLW)
  • Mitralign Inc.
  • Mitralix
  • MitrAssist
  • MVRx
  • NCSI
  • Neovasc
  • OrbusNeich Medical, Inc.
  • Paieon Inc
  • Pharmaceuticals and Medical Devices Agency (PDMA)
  • Phillips
  • Reva Medical
  • Sahajanand Medical Technologies Pvt.
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Siemens AG
  • Singapore Heart Foundation
  • St Jude Medical
  • Surmodics Inc.
  • Sysmetis
  • Tendyne Holdings, Inc.
  • Terumo
  • The Health Science Authority (HSA)
  • The Medical Services Advisory Committee (MSAC)
  • TransCardiac
  • Valtech Cardio
  • Vascular Concepts
  • Venus Medtech Inc.,
  • WHO
Back to Top